SINUS DYNAMICS
DEAD

Serial Number

85562204

Owner

SINUTOPIC, INC.

Attorney

Christine M. Baker

Filing Date

Mar 6, 2012

Add to watchlist:

No watchlists yet
View on USPTO

SINUS DYNAMICS Trademark

Serial Number: 85562204 • Registration: 4445926

SINUS DYNAMICS is a trademark filed by SINUTOPIC, INC. on March 6, 2012. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

SINUTOPIC, INC. (3 trademarks)

755 LAKEFIELD ROAD
WESTLAKE VILLAGE, CA 91361

Entity Type: 03

Trademark Details

Filing Date

March 6, 2012

Registration Date

December 10, 2013

Published for Opposition

September 24, 2013

Cancellation Date

July 17, 2020

Goods & Services

Antibacterial pharmaceuticals; antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; dermatological pharmaceutical products; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; homeopathic pharmaceuticals for use in the treatment of sinusitis; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; inhalers filled with anti-infectives; pharmaceutical anti-allergic preparations and substances; pharmaceutical antitussive-cold preparations ; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of sinusitis; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in dermatology; pharmaceutical products for ophthalmological use; pharmaceutical products for the treatment of viral and infectious diseases and cancer; pharmaceutical products for treating respiratory diseases and asthma; pharmaceuticals, namely, anti-infectives; synthetic peptides for the treatment of sinus conditions and diseases; vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry

Retail pharmacy services; retail store pharmacy services in the field of prescription drugs; mail order pharmacy services; mail order services featuring pharmaceuticals; specialty pharmaceutical distributorship services; pharmaceutical cost management for the health care benefit plans of others; retail and online retail store pharmacy services in the field of prescription drugs, healthcare and beauty products; retail store and mail order pharmacy services in the field of prescription drugs and the distribution of drug therapy information in connection therewith; retail store services, namely, pharmacy, drug and general merchandise store services; mail order of pharmaceuticals, specialty pharmaceutical distributorship services; pharmaceutical cost management for health care benefit plans for others; administering pharmacy reimbursement programs and services; promoting public awareness of the value of using generic drugs; processing mail order prescription drug refill orders in retail and central fill pharmacies; processing online and telephone prescription orders in retail and central fill pharmacies

Pharmaceutical consultation; consulting with patients regarding the administration of medicine and the use of medical devices; providing a physician resource for clinical questions about medications; providing a website featuring information about, and through which, customers can obtain information about general health topics, pharmaceutical therapies and disease state management; providing medical information regarding patients, prescription drugs and drug therapy; providing health care information and consulting services in the field of disease management and medical condition management; providing medical information regarding patients, prescription drugs and drug therapy; developing and managing comprehensive programs involving drug therapy and physican support services in the nature of providing consultation in the dispensing of pharmaceuticals for persons with chronic health issues; therapeutic pharmaceutical services, namely, the development and management of comprehensive programs comprising drug therapy and physician support services in the nature of providing consultation in the dispensing of pharmaceuticals for persons with chronic health issues; drug utilization review dispensing services, namely, identifying possible drug to drug interactions prior to dispensing new prescribed medications and possible drug allergic reactions given a patient's drug allergy history

Filing History

CANCELLED SEC. 8 (6-YR)
Jul 17, 2020 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 10, 2018 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 22, 2017 TCCA
REGISTERED-PRINCIPAL REGISTER
Dec 10, 2013 R.PR
PUBLISHED FOR OPPOSITION
Sep 24, 2013 PUBO
NOTICE OF PUBLICATION
Sep 4, 2013 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 20, 2013 PREV
ASSIGNED TO LIE
Aug 19, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 6, 2013 CNSA
EXAMINERS AMENDMENT MAILED
Aug 6, 2013 CNEA
EXAMINER'S AMENDMENT ENTERED
Aug 5, 2013 XAEC
EXAMINERS AMENDMENT -WRITTEN
Aug 5, 2013 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 10, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 8, 2013 TROA
NON-FINAL ACTION MAILED
Jan 16, 2013 CNRT
NON-FINAL ACTION WRITTEN
Jan 15, 2013 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 22, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 21, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 21, 2012 TROA
NON-FINAL ACTION MAILED
Jun 21, 2012 CNRT
NON-FINAL ACTION WRITTEN
Jun 20, 2012 CNRT
ASSIGNED TO EXAMINER
Jun 13, 2012 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 13, 2012 NWOS